// App-Quantinova.ai

1133 : Four-Factor Prothrombin Complex Concentrate (4-PCC) Effectively Reverses Edoxaban Induced Bleeding In a Rabbit Model Of Acute Injury

Researchers

Presenter

  • Eva Herzog

Principal Investigators

  • Franz Kaspereit

  • Wilfried Krege

  • Ingo Pragst

  • Yoshiyuki Morishima

  • Stefan Schulte

  • Gerhard Dickneite

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • CSL Behring

  • Daiichi Sankyo Compa

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Venous thrombosis

  • Arrhythmia

  • Acute renal failure

  • Stroke

Biomarkers

  • Prothrombin

Drug/Treatment

  • Prothrombin complex

  • Beriplex P/N

  • Edoxaban

  • Evithrom

  • Warfarin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved